MUC1 and bcl-2 expression in preinvasive lesions and adenosquamous carcinoma of the lung

Acta Chirurgica Belgica

Volumn 113, Issue 1, 2013, Pages 19-24

  Demirag, F ^a   Cakir, E ^a   Bayiz, H ^b   Eren Yazici, U ^b  

^a Ataturk Chest Disease and Thoracic Surgery Education and Research Hospital Ankara   (Turkey)

^b Ataturk Chest Disease and Chest Surgery Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84877948266     PISSN: 00015458     EISSN: 25770160     Source Type: Journal    
DOI: 10.1080/00015458.2013.11680879     Document Type: Article

References (13)

1. BRAMBILLA E., TRAVIS W. D. Adenosquamous carcinoma. In: TRAVIS W. D., BRAMBILLA E., MULLER-HERMELINK H. K., HARRIS C. C. (eds.). WHO classification. Pathology & Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004: 51-52.
2. JEANMART M., LANTUEJOUL S., FŒVET F., MORO D., STURM N., BRAMBILLA C. et al. Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer. Clinical Cancer Research, 2003, 9: 2195-2203.
3. ULLMANN R., BONGIOVANNI M., HALBWEDL I., PETZMANN S., Gooo-KAMMERER M., SAPINO A. et al. Bronchiolar columnar cell dyspla-sia-genetic analysis of a novel preneoplastic lesion of peripheral lung. Yirchows Arch, 2003, 442: 429-436.
4. WANG G. F., LAI M. D., YANG R. R., CHEN P. H., Su Y. Y., Lv B. J. et al. Histological types and significance of bronchial epithelial dysplasia. Modern Pathology, 2006, 19: 429-437.
5. KANAZAWA H., EBINA M., INO-OKA N., SHIMIZUKAWA M., TAKAHASHI T. et al. Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung. Am J Pathol, 2000, 156: 1289-1298.
6. BASTIDE K., UGOLIN N., LEVALOIS C, BERNAUDIN J. F., CHEVILLARD S. Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level? Lung Cancer, 2010, 68: 1-9.
7. KANG S.M., KANG H.J., SHIN J. H., KIM H., SHIN D.H. et al. Identical Epidermal Growth Factor Receptor mutations in adeno-carcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung. Cancer, 2007, 109: 581-587.
8. LANTUEJOUL S., SALAMEIRE D., SALON C, BRAMBILLA E. Pulmonary preneoplasia-sequential molecular carcinogenetic events. Histopathology, 2009, 54: 43-54.
9. WAF-1 proteins in lung cancer and premalign lesions: Association with clinical characteristics. Lung, 2002, 179: 265-278.
10. KERR K. M. Pulmonary preinvasive neoplasia. J Clin Pathol, 2001, 54:257-271.
11. PANKIEWICZ W., MINAROWSKI L., NIKLINSKA W., NAUMNIK W., NIKIUNSKI J., CHYCZEWSKI L. Immunohistochemical markers of carcinogenesis in the lung. Folia Histochemica et cytobiologica, 2007, 45:65-74.
12. MASSION P.P., ZOU Y, UNER H., KIATSIMKUL P., WOLF H.J., BARON A. E. et al. Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung career. Plos One, 2009, 4: 1-7.
13. JARRARD J. A., LIONNOILA I., LEE H.R., STEINBERG S.M., WITSCHI H., SZABO E. MUC1 is anovel marker for the type II pneumocyte lineage during lung carcinogenesis. Cancer Research, 1998, 58:5582-5589.